Libri, Vincenzo
Yandim, Cihangir
Athanasopoulos, Stavros
Loyse, Naomi
Natisvili, Theona
Law, Pui Pik
Chan, Ping Kei
Mohammad, Tariq
Mauri, Marta
Tam, Kin Tung
Leiper, James
Piper, Sophie
Ramesh, Aravind
Parkinson, Michael H
Huson, Les
Giunti, Paola
Festenstein, Richard
Clinical trials referenced in this document:
Documents that mention this clinical trial
Documents that mention this clinical trial
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study
https://doi.org/10.1016/s0140-6736(14)60382-2
This article is maintained by: Elsevier
Article Title: Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(14)60382-2
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(14)60573-0
Content Type: article
Copyright: Copyright © 2014 Libri et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.